Activation of the TGF-<i>β</i> Pathway Enhances the Efficacy of Platinum-Based Chemotherapy in Small Cell Lung Cancer Patients

<div>Comparison of the immune-related gene expression in SCLC patients. (a) Expression of immune-related genes in the Local-SCLC cohort. (b) Expression of immune-related genes in the George-SCLC cohort.</div>

Disease Markers

fig4

Figure 4

Figure 4: Activation of the TGF-<i>β</i> Pathway Enhances the Efficacy of Platinum-Based Chemotherapy in Small Cell Lung Cancer Patients 

Disease Markers

Activation of the TGF-β Pathway Enhances the Efficacy of Platinum-Based Chemotherapy in Small Cell Lung Cancer Patients

Figure 4